Changes in Caco-2 cells transcriptome profiles upon exposure to gold nanoparticles

Toxicology Letters

Volumn 233, Issue 2, 2015, Pages 187-199

  Bajak, Edyta ^a   Fabbri, Marco ^a,b   Ponti, Jessica ^a   Gioria, Sabrina ^a   Ojea Jiménez, Isaac ^a   Collotta, Angelo ^a   Mariani, Valentina ^a   Gilliland, Douglas ^a   Rossi, François ^a   Gribaldo, Laura ^a  

^a EUROPEAN COMMISSION   (Belgium)

^b UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

AuNPs uptake; Cellular signaling; QPCR; Stress responses; Transcriptomics

Indexed keywords

CADMIUM; COPPER ION; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE 2; GOLD NANOPARTICLE; HEME OXYGENASE 1; SELENIUM; SELENOPROTEIN; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTOME; ZINC ION;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOINFORMATICS; CACO 2 CELL LINE; CELL MEMBRANE PERMEABILITY; CELL STRESS; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLUTATHIONE METABOLISM; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; MICROARRAY ANALYSIS; OXIDATIVE STRESS; PARTICLE SIZE; PHYLOGENETIC TREE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE; TRANSMISSION ELECTRON MICROSCOPY; TRYPAN BLUE ASSAY; ULTRAVIOLET SPECTROSCOPY; UPREGULATION; ZETA POTENTIAL;

EID: 84964308122     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.12.008     Document Type: Article

References (78)

1. Alexeyenko A., Schmitt T., Tjärnberg A., Guala D., Frings O., Sonnhammer E.L. Comparative interactomics with Funcoup 2.0. Nucleic Acids Res. 2011, 40:D821-D828. 10.1093/nar/gkr1062.
2. Alexiou P., Maragkakis M., Papadopoulos G.L., Simmosis V.A., Zhang L., Hatzigeorgiou A.G. The DIANA-mirExTra web server: from gene expression data to microRNA function. PLoS One 2010, 5:e9171. 10.1371/journal.pone.0009171.
3. Aueviriyavit S., Phummiratch D., Maniratanachote R. Mechanistic study on the biological effects of silver and gold nanoparticles in Caco-2 cells induction of the Nrf2/HO-1 pathway by high concentrations of silver nanoparticles. Toxicol. Lett. 2014, 224:73-83. 10.1016/j.toxlet.2013.09.020.
4. Ayroldi E., Riccardi C. Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J. 2009, 23:3649-3658. 10.1096/fj.09-134684.
5. Bahrami A.H., Raatz M., Agudo-Canalejo J., Michel R., Curtis E.M., Hall C.K., Gradzielski M., Lipowsky R., Weikl T.R. Wrapping of nanoparticles by membranes. Adv. Colloid. Interface Sci. 2014, 208:214-224. 10.1016/j.cis.2014.02.012.
6. Bhattacharya R., Mukherjee P. Biological properties of naked metal nanoparticles. Adv. Drug Deliv. Rev. 2008, 60:1289-1306. 10.1016/j.addr.2008.03.013.
7. Bolstad B.M., Irizarry R.A., Astrand M., Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185-193. 10.1093/bioinformatics/19.2.185.
8. Brigelius-Flohé R., Kipp A.P. Selenium in the redox regulation of the Nrf2 and the Wnt pathway. Methods Enzymol. 2013, 527:65-86. 10.1016/B978-0-12-405882-8.00004-0.
9. Chovatiya R., Medzhitov R. Stress, inflammation, and defense of homeostasis. Mol. Cell. 2014, 54:281-288. 10.1016/j.molcel.2014.03.030.
10. Chuang S.M., Lee Y.H., Liang R.Y., Roam G.D., Zeng Z.M., Tu H.F., Wang S.K., Chueh P.J. Extensive evaluations of the cytotoxic effects of gold nanoparticles. Biochim. Biophys. Acta 1830, 496:4960-4973. 10.1016/j.bbagen.2013.06.025.
11. Connor E.E., Mwamuka J., Gole A., Murphy C.J., Wyatt M.D. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 2005, 1:325-327. 10.1002/smll.200400093.
12. Coradeghini R., Gioria S., García C.P., Nativo P., Franchini F., Gilliland D., Ponti J., Rossi F. Size-dependent toxicity and cell interaction mechanisms of gold nanoparticles on mouse fibroblasts. Toxicol. Lett. 2013, 217:205-216. 10.1016/j.toxlet.2012.11.022.
13. Dubchak I., Munoz M., Poliakov A., Salomonis N., Minovitsky S., Bodmer R., Zambon A.C. Whole-Genome rVISTA: a tool to determine enrichment of transcription factor binding sites in gene promoters from transcriptomic data. Bioinformatics 2013, 129:2059-2061. 10.1093/bioinformatics/btt318.
14. Dubrez-Daloz L., Dupoux A., Cartier J. IAPs: more than just inhibitors of apoptosis proteins. Cell Cycle 2008, 7:1036-1046. 10.4161/cc.7.8.5783.
15. Dykman L., Khlebtsov N. Gold nanoparticles in biomedical applications: recent advances and perspectives. Chem. Soc. Rev. 2012, 41:2256-2282. 10.1039/c1cs15166e.
16. Esther R.J., Bhattacharya R., Ruan M., Bolander M.E., Mukhopadhyay M.E., Sarkar D., Mukherjee G. Gold nanoparticles do not affect the global transcriptional program of human umbilical vein endothelial cells: a DNA microarray analysis. J. Biomed. Nanotechnol. 2005, 3:328-335.
17. Evers B.M. Neurotensin and growth of normal and neoplastic tissues. Peptides 2006, 27:2424-2433. 10.1016/j.peptides.2006.01.028.
18. Flynt A.S., Lai E.C. Biological principles of microRNA-mediated regulation: shared themes amid diversity. Nat. Rev. Genet. 2008, 9:831-842. 10.1038/nrg2455.
19. Fukuda S., Yamasaki Y., Iwaki T., Kawasaki H., Akieda S., Fukuchi N., Tahira T., Hayashi K. Characterization of the biological functions of a transcription factor, c-myc intron binding protein 1 (MIBP1). J. Biochem. 2002, 131:349-357.
20. Fulda S., Gorman A.M., Hori O., Samali A. Cellular stress responses: cell survival and cell death. Int. J. Cell. Biol. 2010, 2010:214074. 10.1155/2010/214074.
21. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., Ellis B., Gautier L., Ge Y., Gentry J., et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004, 5:R80. 10.1186/gb-2004-5-10r80.
22. Gioria S., Chassaigne H., Carpi D., Parracino A., Meschini S., Barboro P., Rossi F. A proteomic approach to investigate AuNPs effects in Balb/3T3 cells. Toxicol. Lett. 2014, 228:111-126. 10.1016/j.toxlet.2014.04.016.
23. Gozzelino R., Jeney V., Soares M.P. Mechanisms of cell protection by heme oxygenase-1. Annu. Rev. Pharmacol. Toxicol. 2010, 50:323-354. 10.1146/annurev.pharmtox.010909.105600.
24. Hainfeld J.F., Slatkin D.N., Focella T.M., Smilowitz H.M. Gold nanoparticles: a new X-ray contrast agent. Br. J. Radiol. 2006, 79:248-253. 10.1259/bjr/13169882.
25. Haiss W., Thanh N.T.K., Aveyard J., Fernig D.G. Determination of size and concentration of gold nanoparticles from UV-vis spectra. Anal. Chem. 2007, 79:4215-4221. 10.1021/ac0702084.
26. Hamadeh H.K., Amin R.P., Paules R.S., Afshari C.A. An overview of toxicogenomics. Curr. Issues Mol. Biol. 2002, 4:45-56.
27. Hay R.T. SUMO: a history of modification. Mol. Cell. 2005, 18:1-12. 10.1016/j.molcel.2005.03.012.
28. Kensler T.W., Wakabayashi N., Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 2007, 47:89-116. 10.1146/annurev.pharmtox.46.120604.141046.
29. Kunzmann A., Andersson B., Thurnherr T., Krug H., Scheynius A., Fadeel B. Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation. Biochim. Biophys. Acta 2011, 1810:361-373. 10.1016/j.bbagen.2010.04.007.
30. Labens R., Lascelles B.D., Charlton A.N., Ferrero N.R., Van Wettere A.J., Xia X.R., Blikslager A.T. Ex vivo effect of gold nanoparticles on porcine synovial membrane. Tissue Barriers 2013, 1:e24314. 10.4161/tisb.24314.
31. Laukens D., Waeytens A., De Bleser P., Cuvelier C., De Vos M. Human metallothionein expression under normal and pathological conditions: mechanisms of gene regulation based on in silico promoter analysis. Crit. Rev. Eukaryot. Gene Expression 2009, 19:301-317. 10.1615/CritRevEukarGeneExpr.v19. i4.40.
32. Li K., Schneider M. Quantitative evaluation and visualization of size effect on cellular uptake of gold nanoparticles by multiphoton imaging-UV/vis spectroscopic analysis. J. Biomed. Opt. 2014, 19:101505. 10.1117/1. JBO.19.10.101505.
33. Li R., Chen W., Yanes R., Lee S., Berliner J.A. OKL38 is an oxidative stress response gene stimulated by oxidized phospholipids. J. Lipid Res. 2006, 48:709-715. 10.1194/jlr.M600501-JLR200.
34. Li J.J., Lo S.L., Ng C.T., Gurung R.L., Hartono D., Hande M.P., Ong C.N., Bay B.H., Yung L.Y. Genomic instability of gold nanoparticle treated human lung fibroblast cells. Biomaterials 2011, 32:5515-5523. 10.1016/j.biomaterials.2011.04.023.
35. Li N., Zhao P., Astruc D. Anisotropic gold nanoparticles: synthesis, properties, applications, and toxicity. Angew. Chem. Int. Ed. Engl. 2014, 53:1756-1789. 10.1002/anie.201300441.
36. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262.
37. Masters B.A., Quaife C.J., Erickson J.C., Kelly E.J., Froelick G.J., Zambrowicz B.P., Brinster R.L., Palmiter R.D. Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles. J. Neurosci. 1994, 14:5844-5857.
38. Maynard R.L. Nano-technology and nano-toxicology. Emerg. Health Threats J. 2012, 5:17508. 10.3402/ehtj.v5i0.17508.
39. Meyer T.E., Habener J.F. Cyclic adenosine 3',5'-monophosphate response element binding protein (CREB) and related transcription-activating deoxyribonucleic acid-binding proteins. Endocr. Rev. 1993, 14:269-290. 10.1210/edrv-14-3-269.
40. Miles A.T., Hawksworth G.M., Beattie J.H., Rodilla V. Induction regulation, degradation, and biological significance of mammalian metallothioneins. Crit. Rev. Biochem. Mol. Biol. 2000, 35:35-70.
41. Mironava T., Hadjiargyrou M., Simon M., Rafailovich M.H. Gold nanoparticles cellular toxicity and recovery: adipose derived stromal cells. Nanotoxicology 2014, 8:189-201. 10.3109/17435390.2013.769128.
42. Natoli M., Leoni B.D., D'Agnano I., D'Onofrio M., Brandi R., Arisi I., Zucco F., Felsani A. Cell growing density affects the structural and functional properties of Caco-2 differentiated monolayer. J. Cell Physiol. 2011, 226(6):1531-1543. 10.1002/jcp.22487.
43. Natoli M., Leoni B.D., D'Agnano I., Zucco F., Felsani A. Good Caco-2 cell culture practices. Toxicol. In Vitro 2012, 26(8):1243-1246. 10.1016/j.tiv.2012.03.009.
44. Nel A.E., Mädler L., Velegol D., Xia T., Hoek E.M., Somasundaran P., Klaessig F., Castranova V., Thompson M. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 2009, 8:543-557. 10.1038/nmat2442.
45. Oh N., Park J.-H. Endocytosis and exocytosis of nanoparticles in mammalian cells. Int. J. Nanomed. 2014, 9(Suppl. 1):51-63. 10.2147/IJN.S26592.
46. Oku S., Takahashi N., Fukata Y., Fukata M. In silico screening for palmitoyl substrates reveals a role for DHHC1/3/10 (zDHHC1/3/11)-mediated neurochondrin palmitoylation in its targeting to Rab5-positive endosomes. J. Biol. Chem. 2013, 288:19816-19829. 10.1074/jbc.M112.431676.
47. Papp L.V., Holmgren A., Khanna K.K. Selenium and selenoproteins in health and disease. Antioxid. Redox Signal. 2010, 12:793-795. 10.1089/ars.2009.2973.
48. Parthun M.R. Hat1: the emerging cellular roles of a type B histone acetyltransferase. Oncogene 2007, 26:5319-5328. 10.1038/sj.onc.1210602.
49. Pernodet N., Fang X., Sun Y., Bakhtina A., Ramakrishnan A., Sokolov J., Ulman A., Rafailovich M. Adverse effects of citrate/gold nanoparticles on human dermal fibroblasts. Small 2006, 2:766-773. 10.1002/smll.200500492.
50. Ponti J., Colognato R., Rauscher H., Gioria S., Broggi F., Franchini F., Pascual C., Giudetti G., Rossi F. Colony forming efficiency and microscopy analysis of multi-wall carbon nanotubes cell interaction. Toxicol. Lett. 2010, 197:29-37. 10.1016/j.toxlet.2010.04.018.
51. Qiu X.B., Shao Y.M., Miao S., Wang L. The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperones. Cell. Mol. Life Sci. 2006, 63:2560-2570. 10.1007/s00018-006-6192-6.
52. Qu Y., Huang Y., Lü X. Proteomic analysis of molecular biocompatibility of gold nanoparticles to human dermal fibroblasts-fetal. J. Biomed. Nanotechnol. 2013, 9:40-52. 10.1166/jbn.2013.1428.
53. Quaife C.J., Findley S.D., Erickson J.C., Froelick G.J., Kelly E.J., Zambrowicz B.P., Palmiter R.D. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry 1994, 33:7250-7259. 10.1021/bi00189a029.
54. Rothbarth K., Spiess E., Juodka B., Yavuzer U., Nehls P., Stammer H., Werner D. Induction of apoptosis by overexpression of the DNA-binding and DNA-PK-activating protein C1D. J. Cell Sci. 1999, 112:2223-2232.
55. Sambuy Y., De Angelis I., Ranaldi G., Scarino M.L., Stammati A., Zucco F. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics?. Altern. Lab. Anim. 2005, 33(6):603-618.
56. Schütz C.A., Juillerat-Jeanneret L., Mueller H., Lynch I., Riediker M. Therapeutic nanoparticles in clinics and under clinical evaluation. Nanomedicine 2013, 8:449-467. 10.2217/nnm.13.8.
57. Schomburg L., Schweizer U. Hierarchical regulation of selenoprotein expression and sex-specific effects of selenium. Biochim. Biophys. Acta 2009, 1790:1453-1462. 10.1016/j.bbagen.2009.03.015.
58. Shelton P., Jaiswal A.K. The transcription factor NF-E2-related factor 2 (Nrf2): a protooncogene?. FASEB J. 2013, 27:414-423. 10.1096/fj.12-217257.
59. Shin C., Kleiman F.E., Manley J.L. Multiple properties of the splicing repressor SRp38 distinguish it from typical SR proteins. Mol. Cell. Biol. 2005, 25:8334-8343. 10.1128/MCB.25.18.8334-8343.2005.
60. Smyth G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004, 3:1-25. (Article 3). 10.2202/1544-6115.1027.
61. Soenen S.J., Manshian B., Montenegro J.M., Amin F., Meermann B., Thiron T., Cornelissen M., Vanhaecke F., Doak S., Parak W.J., et al. Cytotoxic effects of gold nanoparticles: a multiparametric study. ACS Nano 2012, 6:5767-5783. 10.1021/nn301714n.
62. Staggers N., McCasky T., Brazelton N., Kennedy R. Nanotechnology: the coming revolution and its implications for consumers, clinicians, and informatics. Nurs. Outlook 2008, 56:268-274. 10.1016/j.outlook.2008.06.004.
63. Tadiali M., Seidelin J.B., Olsen J., Troelsen J.T. Transcriptome changes during intestinal cell differentiation. Biochim. Biophys. Acta 2002, 1589(2):160-167.
64. Talukder A.H., Meng Q., Kumar R. CRIPak a novel endogenous Pak1 inhibitor. Oncogene 2006, 25:1311-1319. 10.1038/sj.onc.1209172.
65. Thomson R.B., Igarashi P., Biemesderfer D., Kim R., Abu-Alfa A., Soleimani M., Aronson P.S. Isolation and cDNA cloning of Ksp-cadherin, a novel kidney-specific member of the cadherin multigene family. J. Biol. Chem. 1995, 270:17594-17601. 10.1074/jbc.270.29.17594.
66. Tremblay E., Auclair J., Delvin E., Levy E., Ménard D., Pshezhetsky A.V., Rivard N., Seidman E.G., Sinnett D., Vachon P.H., Beaulieu J.F. Gene expression profiles of normal proliferating and differentiating human intestinal epithelial cells: a comparison with the Caco-2 cell model?. J. Cell Biochem. 2006, 99(4):1175-1186.
67. Turkevich J., Stevenson P.C., Hillier J. A study of nucleation and growth process in the synthesis of colloidal gold. Discuss. Faraday Soc. 1951, 11:55-75.
68. Ullah S., John P., Bhatti A. MicroRNAs with a role in gene regulation and in human diseases. Mol. Biol. Rep. 2014, 41:225-232. 10.1007/s11033-013-2855-1.
69. Vašák M., Meloni G. Chemistry and biology of mammalian metallothioneins. J. Biol. Inorg. Chem. 2011, 16:1067-1078. 10.1007/s00775-011-0799-2.
70. Vendrell J., Querol E., Avilés F.X. Metallocarboxypeptidases and their protein inhibitors. Structure, function and biomedical properties. Biochim. Biophys. Acta 1477, 28:4-298. 10.1016/S0167-4838(99)00280-0.
71. Venkatesh S., Workman J.L., Smolle M. UpSETing chromatin during non-coding RNA production. Epigenetics Chromatin 2013, 6:16. 10.1186/1756-8935-6-16.
72. Walker M.S., Hughes T.A. Messenger RNA expression profiling using DNA microarray technology: diagnostic tool, scientific analysis or un-interpretable data?. Int. J. Mol. Med. 2008, 21:13-17. 10.3892/ijmm.21.1.13.
73. Wang S.H., Lee C.W., Chiou A., Wei P.K. Size-dependent endocytosis of gold nanoparticles studied by three-dimensional mapping of plasmonic scattering images. J. Nanobiotechnol. 2010, 8:33. 10.1186/1477-3155-8-33.
74. Wingler K., Böcher M., Flohé L., Kollmus H., Brigelius-Flohé R. mRNA stability and selenocysteine insertion sequence efficiency rank gastrointestinal glutathione peroxidase high in the hierarchy of selenoproteins. Eur. J. Biochem. 1999, 259:149-157. 10.1046/j.1432-1327.19999.00012.x.
75. Wittmaack K. Excessive delivery of nanostructured matter to submersed cells caused by rapid gravitational settling. ACS Nano 2011, 5:3766-3778. 10.1021/nn200112u.
76. Yang Y., Qu Y., Lü X. Global gene expression analysis of the effects of gold nanoparticles on human dermal fibroblasts. J. Biomed. Nanotechnol. 2010, 6:234-246. 10.1166/jbn.2010.1128.
77. Zhang Y., Yuan F., Wu X., Wang M., Rechkoblit O., Taylor J.S., Geacintov N.E., Wang Z. Error-free and error-prone lesion bypass by human DNA polymerase kappa in vitro. Nucleic Acids Res. 2000, 28:4138-4146.
78. Zhang S.L., Tang Y.P., Wang T., Yang J., Rao K., Zhao L.Y., Zhu W.Z., Meng X.H., Wang S.G., Liu J.H., et al. Clinical assessment and genomic landscape of a consanguineous family with three Kallmann syndrome descendants. Asian J. Androl. 2011, 13:166-171. 10.1038/aja.2010.83.